1. From University of Rochester Cancer Center Community Clinical Oncology Program Research Base, Rochester, New York; Metro-Minnesota Community Clinical Oncology Program, St. Louis Park, Minnesota; Wichita Community Clinical Oncology Program, Wichita, Kansas; Northern New Jersey Community Clinical Oncology Program, Hackensack, New Jersey; Syracuse Hematology-Oncology Community Clinical Oncology Program, Syracuse, New York; and Northwest Community Clinical Oncology Program, Tacoma, Washington.